1. Home
  2. LSH vs PMN Comparison

LSH vs PMN Comparison

Compare LSH & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSH
  • PMN
  • Stock Information
  • Founded
  • LSH 2018
  • PMN 2004
  • Country
  • LSH United States
  • PMN Canada
  • Employees
  • LSH N/A
  • PMN N/A
  • Industry
  • LSH
  • PMN Pharmaceuticals and Biotechnology
  • Sector
  • LSH
  • PMN Health Care
  • Exchange
  • LSH NYSE
  • PMN Nasdaq
  • Market Cap
  • LSH 28.6M
  • PMN 32.3M
  • IPO Year
  • LSH 2024
  • PMN N/A
  • Fundamental
  • Price
  • LSH $2.80
  • PMN $1.00
  • Analyst Decision
  • LSH
  • PMN
  • Analyst Count
  • LSH 0
  • PMN 0
  • Target Price
  • LSH N/A
  • PMN N/A
  • AVG Volume (30 Days)
  • LSH 25.4K
  • PMN 89.6K
  • Earning Date
  • LSH 11-26-2024
  • PMN 11-19-2024
  • Dividend Yield
  • LSH N/A
  • PMN N/A
  • EPS Growth
  • LSH N/A
  • PMN N/A
  • EPS
  • LSH N/A
  • PMN N/A
  • Revenue
  • LSH $18,315,155.00
  • PMN N/A
  • Revenue This Year
  • LSH N/A
  • PMN N/A
  • Revenue Next Year
  • LSH N/A
  • PMN N/A
  • P/E Ratio
  • LSH N/A
  • PMN N/A
  • Revenue Growth
  • LSH 42.28
  • PMN N/A
  • 52 Week Low
  • LSH $2.10
  • PMN $0.92
  • 52 Week High
  • LSH $5.37
  • PMN $3.10
  • Technical
  • Relative Strength Index (RSI)
  • LSH N/A
  • PMN 43.64
  • Support Level
  • LSH N/A
  • PMN $0.97
  • Resistance Level
  • LSH N/A
  • PMN $1.08
  • Average True Range (ATR)
  • LSH 0.00
  • PMN 0.13
  • MACD
  • LSH 0.00
  • PMN -0.00
  • Stochastic Oscillator
  • LSH 0.00
  • PMN 3.35

About LSH LAKESIDE HOLDING LTD

Lakeside Holding Ltd i a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea. It provides customized cross-border ocean freight solutions and airfreight solutions in the U.S, including (i) cross-border freight consolidation and forwarding services, (ii) customs clearance services, (iii) warehousing and distribution services and (iv) U.S. domestic ground transportation services.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: